New approaches to the management of COPD

Chest

Volumn 117, Issue 2 SUPPL., 2000, Pages 58S-62S

  Stockley, Robert A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Antiproteases; COPD; Inflammation; Neutrophil elastase; Neutrophils

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; ELASTIN; LEUKOCYTE ELASTASE; MUSCARINIC M3 RECEPTOR ANTAGONIST; OXIDIZING AGENT;

CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; INFLAMMATION; NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0033998256     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.2_suppl.58S     Document Type: Article

References (20)

1. Currie DC, Pavia D, Agnew J, et al. Impaired tracheobronchial clearance in bronchiectasis. Thorax 1987; 42:126-130
2. 1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15:132-140
3. Lucey EC, Stone PJ, Breuer R, et al. Effect of combined human neutrophil cathepsin G and elastase on induction of secretory cell metaplasia and emphysema in hamsters with in vivo observations on elastolysis by these enzymes. Am Rev Respir Dis 1985; 132:363-366
4. Stockley RA. The pathogenesis of chronic obstructive lung diseases: implications for therapy. Q J Med 1995; 88:141-146
5. Stockley RA. Chronic bronchitis: the antiprotease/protease balance and the effect of infection and corticosteroids. Clin Chest Med 1998; 9:643-656
6. Liou TG, Campbell EJ. Non-isotropic enzyme-inhibitor interactions: a novel non-oxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry 1995; 34: 16171-16177
7. Liou TG, Campbell EJ. Quantum proteolysis resulting from release of single granules by human neutrophils. J Immunol 1996; 157:2624-2631
8. Sallenave JM, Shulmann J, Crossley J, et al. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1995; 11:733-741
9. Burnett D, Chamba A, Hill SL, Stockley RA. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extra cellular proteolysis. Lancet 1987; 2:1043-1046
10. Di Stefano A, Maestrelli P, Roggeri A, et al. Up-regulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive pulmonary bronchitis. Am J Respir Crit Care Med 1994; 141:803-810
11. Mikami M, Llewellyn-Jones CG, Bayley D, et al. The chemotactic activity of sputum from patients with bronchiectasis. Am J Respir Crit Care Med 1998; 157:723-728
12. Llewellyn-Jones C, Johnson MM, Mitchell JL, et al. In vivo study of indomethacin in bronchiectasis: effect on neutrophil function and lung secretions. Eur Respir J 1995; 8:1479-1487
13. Lomas DA, Stone SR, Llewellyn-Jones C, et al. The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin. J Biol Chem 1995; 270:23437-23443
14. Parmentier M, Drost E, Hirani N, et al. 1999. Thiol antioxidants inhibit neutrophil chemotaxis by decreasing release of IL8 from macrophages and pulmonary epithelial cells. Am J Respir Crit Care Med (in press)
15. Selby C, Drost E, Lannan S, et al. Neutrophil retention in the lungs of patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1991; 143:1359-1364
16. Britton JR, Pavord ID, Richards KA, et al. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 1995; 151:1383-1387
17. Weiss SJ, Lampert MB, Test ST. Long lived oxidants generated by human neutrophils: characterization and bio-activity. Science 1983; 222:626-628
18. British Thoracic Research Committee. Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. Thorax 1985; 40:823-835
19. Rasmusse JB, Glennow C. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled release tablets in patients with chronic bronchitis. Eur J Respir Dis 1998; 1:351-355
20. Smith CAD, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydralase and susceptibility to emphysema. Lancet 1997; 350:630-633